REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
|Articles|October 13, 2021
Daily OTC Pearl: Vitamin B-6
Author(s)Saro Arakelians, PharmD
People with kidney disease or conditions that prevent the small intestine from absorbing nutrients from foods are more likely to be vitamin B-6 deficient.
Advertisement
OTC/Lifestyle Pearl of the Day: Vitamin B-6
Indication: Vitamin B-6 (pyridoxine) is important for normal brain development and for keeping the nervous system and immune system healthy.
Insight:
- Food sources of vitamin B-6 include poultry, fish, potatoes, chickpeas, bananas, and fortified cereals.
- Vitamin B-6 can also be taken as a supplement, typically as an oral capsule, tablet, or liquid.
- People with kidney disease or conditions that prevent the small intestine from absorbing nutrients from foods (malabsorption syndromes) are more likely to be vitamin B-6 deficient.
- A vitamin B-6 deficiency is usually coupled with deficiency in other B vitamins, such as folic acid (vitamin B-9) and vitamin B-12.
- Interactions may include with altretamine, barbiturates, anticonvulsants, and levodopa.
- Recommended daily allowance: The recommended daily amount of vitamin B-6 for adults 50 years of age and younger is 1.3 milligrams. After age 50, the recommended daily amount is 1.5 milligrams for women and 1.7 milligrams for men.
Sources:
Advertisement
Related to this article
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
The once-nightly drop, previously approved to reverse pupil dilation, met its primary end point in 2 phase 3 trials, with conjunctival hyperemia most common.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
Recap: Tirzepatide Is Approved to Cut Cardiovascular Risk in Type 2 Diabetes
4
Oncology Pharmacists Reduce Adverse Drug Reactions in Hematologic Cancer Care
5